A clinical trial of^(153)Sm-EDTMP in promotion of bone metastatic cancer pains  

作　　者：王新 

出　　处：《中国临床康复》2002年第10期1539-1539,共1页Chinese Journal of Clinical Rehabilitation

摘　　要：Objective To evaluate the effect of 153 Sm-EDTMP in the bone metastatic cancer pains.Methods In treatment group(32patients with bone metastatic diseases) 153 Sm-EDTMP were given by infusion for o ne time.In control group,32patient s received radiotherapy.The ra-dio-dose was DT30Gy,5times per week for 2weeks.Pain relief was used as criteria of response at the time treatm ent finished and 6months later.Results At the time treatment finished,there were statistically differences in pain relief between two groups.Pain s relief rate was superior to control group after 6months(P <0.05).Conclusion Treatment with 153 Sm-EDTMP one time can reduce apparen tly pains caused by bone metastases,which is conveniently u sed and well tolerated.Objective To evaluate the effect of 153 Sm-EDTMP in the bone metastatic cancer pains.Methods In treatment group(32patients with bone metastatic diseases) 153 Sm-EDTMP were given by infusion for o ne time.In control group,32patient s received radiotherapy.The ra-dio-dose was DT30Gy,5times per week for 2weeks.Pain relief was used as criteria of response at the time treatm ent finished and 6months later.Results At the time treatment finished,there were statistically differences in pain relief between two groups.Pain s relief rate was superior to control group after 6months(P <0.05).Conclusion Treatment with 153 Sm-EDTMP one time can reduce apparen tly pains caused by bone metastases,which is conveniently u sed and well tolerated.

关 键 词：^153钐 骨转移癌 癌痛 疗效 

分 类 号：R738.1[医药卫生—肿瘤]